Cor­rect­ed: Prime Med­i­cine part­ners with Ver­sant-backed biotech to de­vel­op safer stem cell trans­plants

Prime Med­i­cine and Cimeio Ther­a­peu­tics are part­ner­ing to de­vel­op gene-edit­ed stem cell treat­ments for two kinds of bone mar­row can­cers and oth­er po­ten­tial ge­net­ic dis­eases …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER